Table 2.
Currently used and preferred contraceptive methods for future use among HIV-infected men and women
| Method Method | Currently used any FP methods freq (%) | Preferred FP method for future use freq (%) (%ge)(%ge) | ||||
|---|---|---|---|---|---|---|
| Men (n = 441) | Women (n = 659) | All (n = 1100) | Men (n = 441) | Women (n = 659) | All (n = 1100)* | |
| Male methods | ||||||
| Male condoms | 272 (61.8) | 258 (39.2) | 530 (48.2) | 355 (80.5) | 419 (63.6) | 774(70.4) |
| Male sterilization | 0 (0) | 0 (0) | 0 (0) | 65 (14.7) | 85 (12.9) | 150 (13.6) |
| Female methods | ||||||
| Injectable | 21 (4.8) | 58 (8.8) | 79 (7.1) | 111 (25.2) | 228 (34.6) | 339 (30.8) |
| Pill | 9 (2.0) | 23 (3.5) | 32 (2.9) | 92 (20.9) | 126 (19.1) | 218 (19.8) |
| Implants | 11 (2.5) | 15 (2.3) | 26 (2.4) | 81 (18.4) | 118 (17.9) | 199 (18.1) |
| Female sterilization | 4 (0.9) | 9 (1.4) | 13 (1.2) | 62 (11.1) | 114 (17.3) | 176 (16.0) |
| Female condoms | 5 (1.1) | 5 (0.8) | 10 (0.9) | 96 (21.8) | 129 (19.6) | 225 (20.5) |
| Emergency contraception | 3 (0.7) | 1 (0.2) | 4 (0.4) | 65 (14.7) | 115 (17.5) | 180 (16.4) |
| IUD | 0.0 (0) | 1 (0.2) | 1 (0.1) | 39 (8.8) | 45 (6.8) | 84 (7.6) |
| Diaphragm | 0 (0) | 1 (0.2) | 0 (0.09) | 33 (7.5) | 39 (5.9) | 72 (6.6) |
| Foam/jelly | 0 (0.0) | 3 (0.5) | 3 (0.3) | 46 (10.4) | 94 (14.3) | 140 (12.7) |
| Natural methods | ||||||
| Withdrawal | 23 (5.2) | 17 (2.6) | 40 (3.6) | 102 (23.1) | 156 (23.7) | 258 (23.5) |
| Rhythm method | 12 (2.7) | 18 (2.7) | 30 (2.7) | 106 (24.0) | 136 (20.6) | 242 (22.0) |
| Lactational Amenorrhoea | 5 (1.1) | 16 (2.4) | 21 (1.9) | 80 (18.4) | 125 (19.0) | 205 (18.6) |
| Using any FP method | 300 (68.0) | 340 (51.6) | 640 (58.2) | - | - | - |
| Using dual FP methods | 54 (12.2) | 71 (10.8) | 125 (11.4) | |||
*Some respondents selected more than one preferred FP method